101 related articles for article (PubMed ID: 10318952)
1. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis.
Cao R; Wu HL; Veitonmäki N; Linden P; Farnebo J; Shi GY; Cao Y
Proc Natl Acad Sci U S A; 1999 May; 96(10):5728-33. PubMed ID: 10318952
[TBL] [Abstract][Full Text] [Related]
2. Role of plasminogen activator-plasmin system in tumor angiogenesis.
Rakic JM; Maillard C; Jost M; Bajou K; Masson V; Devy L; Lambert V; Foidart JM; Noël A
Cell Mol Life Sci; 2003 Mar; 60(3):463-73. PubMed ID: 12737307
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of in vivo angiogenesis and tumor growth by a novel cyclooxygenase-2 inhibitor, enoic acanthoic acid.
Jung HJ; Shim JS; Suh YG; Kim YM; Ono M; Kwon HJ
Cancer Sci; 2007 Dec; 98(12):1943-8. PubMed ID: 17888030
[TBL] [Abstract][Full Text] [Related]
4. New functional aspects of cathepsin D and cathepsin E.
Tsukuba T; Okamoto K; Yasuda Y; Morikawa W; Nakanishi H; Yamamoto K
Mol Cells; 2000 Dec; 10(6):601-11. PubMed ID: 11211863
[TBL] [Abstract][Full Text] [Related]
5. The hemostatic system and angiogenesis in malignancy.
Wojtukiewicz MZ; Sierko E; Klement P; Rak J
Neoplasia; 2001; 3(5):371-84. PubMed ID: 11687948
[TBL] [Abstract][Full Text] [Related]
6. Beyond cancer cells: Targeting the tumor microenvironment with gene therapy and armed oncolytic virus.
Wan PK; Ryan AJ; Seymour LW
Mol Ther; 2021 May; 29(5):1668-1682. PubMed ID: 33845199
[TBL] [Abstract][Full Text] [Related]
7. Dual roles of endothelial FGF-2-FGFR1-PDGF-BB and perivascular FGF-2-FGFR2-PDGFRβ signaling pathways in tumor vascular remodeling.
Hosaka K; Yang Y; Nakamura M; Andersson P; Yang X; Zhang Y; Seki T; Scherzer M; Dubey O; Wang X; Cao Y
Cell Discov; 2018; 4():3. PubMed ID: 29423271
[TBL] [Abstract][Full Text] [Related]
8. The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages.
Yang Y; Andersson P; Hosaka K; Zhang Y; Cao R; Iwamoto H; Yang X; Nakamura M; Wang J; Zhuang R; Morikawa H; Xue Y; Braun H; Beyaert R; Samani N; Nakae S; Hams E; Dissing S; Fallon PG; Langer R; Cao Y
Nat Commun; 2016 May; 7():11385. PubMed ID: 27150562
[TBL] [Abstract][Full Text] [Related]
9. Plasmid transfer of plasminogen K1-5 reduces subcutaneous hepatoma growth by affecting inflammatory factors.
Koch LA; Schmitz V; Strassburg CP; Raskopf E
Biomed Res Int; 2014; 2014():656527. PubMed ID: 24895598
[TBL] [Abstract][Full Text] [Related]
10. Human placenta mesenchymal stem cells expressing exogenous kringle1-5 protein by fiber-modified adenovirus suppress angiogenesis.
Chu Y; Liu H; Lou G; Zhang Q; Wu C
Cancer Gene Ther; 2014 May; 21(5):200-8. PubMed ID: 24853622
[TBL] [Abstract][Full Text] [Related]
11. VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival.
Religa P; Cao R; Religa D; Xue Y; Bogdanovic N; Westaway D; Marti HH; Winblad B; Cao Y
Sci Rep; 2013; 3():2053. PubMed ID: 23792494
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.
Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R
BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393
[TBL] [Abstract][Full Text] [Related]
13. Mediators of ocular angiogenesis.
Qazi Y; Maddula S; Ambati BK
J Genet; 2009 Dec; 88(4):495-515. PubMed ID: 20090210
[TBL] [Abstract][Full Text] [Related]
14. Residues essential for plasminogen binding by the cation-independent mannose 6-phosphate receptor.
Bohnsack RN; Patel M; Olson LJ; Twining SS; Dahms NM
Biochemistry; 2010 Jan; 49(3):635-44. PubMed ID: 20028034
[TBL] [Abstract][Full Text] [Related]
15. A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells.
Yi ZF; Cho SG; Zhao H; Wu YY; Luo J; Li D; Yi T; Xu X; Wu Z; Liu M
Int J Cancer; 2009 Feb; 124(4):843-52. PubMed ID: 19035465
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis.
Nissen LJ; Cao R; Hedlund EM; Wang Z; Zhao X; Wetterskog D; Funa K; Bråkenhielm E; Cao Y
J Clin Invest; 2007 Oct; 117(10):2766-77. PubMed ID: 17909625
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer for the treatment of neovascular ocular disease (an American Ophthalmological Society thesis).
Stout JT
Trans Am Ophthalmol Soc; 2006; 104():530-60. PubMed ID: 17471360
[TBL] [Abstract][Full Text] [Related]
18. Liposome-mediated gene transfer of K1-5 suppresses tumor development and improves the prognosis of hepatocellular carcinoma in mice.
Torimura T; Ueno T; Sata M
Med Mol Morphol; 2006 Jun; 39(2):72-8. PubMed ID: 16821144
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model.
Schmitz V; Raskopf E; Gonzalez-Carmona MA; Vogt A; Rabe C; Leifeld L; Kornek M; Sauerbruch T; Caselmann WH
Gut; 2007 Feb; 56(2):271-8. PubMed ID: 16809420
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin in relation to childhood myeloblastic leukaemia.
Petridou E; Mantzoros CS; Dessypris N; Dikalioti SK; Trichopoulos D
Br J Cancer; 2006 Jan; 94(1):156-60. PubMed ID: 16404369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
